Filing Details
- Accession Number:
- 0001178913-12-002265
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-13 16:53:34
- Reporting Period:
- 2012-01-19
- Filing Date:
- 2012-08-13
- Accepted Time:
- 2012-08-13 16:53:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1321502 | Andain Inc. | ANDN | Pharmaceutical Preparations (2834) | 202066406 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1328099 | Elimelech Sam Shlomo | 400 South Beverly Drive, Suite 312 Beverly Hills CA 90212 | President | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-01-19 | 1,000 | $0.12 | 4,531,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2012-01-26 | 1,000 | $0.95 | 4,532,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2012-01-26 | 1,000 | $0.10 | 4,533,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2012-02-01 | 1,000 | $0.15 | 4,534,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2012-02-16 | 5,000 | $0.12 | 4,539,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2012-02-27 | 2,471,878 | $0.00 | 7,010,878 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2012-03-08 | 5,000 | $0.10 | 7,015,878 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- These shares were purchase directly from Pangea Investments GmbH, a former affiliate of the company controlled by Ralph W. Marthaler.
- In computing the number of shares beneficially owned by this stockholder, shares of common stock subject to options or convertible or exchangeable into such shares of common stock held by that person that are currently exercisable, or exercisable within 60 days, are included. Therefore, 330,000 of the total consists of shares of common stock underlying the vested and exercisable (as of January 1, 2012) portion of a stock option for 990,000 shares of common stock granted by the Company in exchange for services rendered to the Company.
- 150,000 shares of common stock are owned indirectly by Mr. Elimelech in accordance with Rule 13d-3 under the1934 Act (they are held by members of Mr. Elimelech's household).
Billionaire Hedge Funds
